SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jul 8, 2026

BLLN

BillionToOne, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $270K total
Actionable Insight • Neutral

The insider cluster is too small relative to market cap to carry a directional signal. Monitor for any unusual acceleration in insider selling or a change in pattern (e.g., non-10b5-1 sales). The lease expansion is a positive operational catalyst, but this cluster does not alter that view.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
BLLN ▼ -17.25% at T+60d
NEUTRAL call -17.25% · α vs SPY -19.89% · entry $127.97 → $105.90
Entry = T+0 close
Jul 8, 2026
via day close
T+1d
-0.94%
call -0.94% · α -1.37%
$126.77
settled 4mo ago
T+5d
+0.16%
call +0.16% · α +0.30%
$128.18
settled 3mo ago
T+20d
-28.38%
call -28.38% · α -30.62%
$91.65
settled 3mo ago
T+60d
-17.25%
call -17.25% · α -19.89%
$105.90
settled 26d ago

Price Chart

Loading chart...

Executive Summary

BillionToOne insiders, including CEO Atay Oguzhan, sold ~$3.12M in shares over a 7-day window, representing less than 0.1% of the $5.5B market cap. The CEO's sales coincided with option exercises, suggesting a tax-motivated cashless exercise pattern. A recent 8-K (June 29) disclosed a major lease expansion, but the insider selling appears routine in size and structure.

Key Financial Metrics

Direction
selling
Total Value
$3.1M
Insiders
3

Key Facts

  • CEO Atay Oguzhan sold ~$2.85M in open-market shares on July 6, paired with option exercises of 46,250 shares at $2.80.
  • Two other insiders (ten Bosch, Johnson) sold a combined $270K on June 29 and July 1.
  • Total insider sales of ~$3.12M represent only 0.057% of BLLN's $5.5B market cap.
  • A June 29 8-K announced a 12-year lease for ~62,659 sq ft with $46.7M in aggregate rent, triple oncology lab space, reflecting strong test volume growth.

Financial Impact

Insider sales of ~$3.12M, or 0.057% of market cap — de minimis.

dilution (option exercises)

Risk Factors

  • CEO sales could increase if the stock continues to rise, potentially creating overhang.
  • No material risk from current cluster.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
79% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BLLN-1783577510728
29 reports for BLLN
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 9 of 9 best @ T+60▲ +26.26%Mar 4, 2026
Filters
Rows
Reports for BLLN — sortable, filterable
TypeNow
Sep 30, 2026
26d ago
Insider Cluster
BEARISH ★ 5/10
$105.76awaiting T+60—$111.46 (−5.39%)
Sep 28, 2026
28d ago
Insider Cluster
BEARISH ★ 5/10
$118.18awaiting T+60—$111.46 (+5.68%)
Sep 23, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$124.90awaiting T+60—$111.46 (+10.76%)
Sep 22, 2026
4w ago
Institutional Cluster
BULLISH ★ 4/10
$116.07awaiting T+60—$111.46 (−3.97%)
Sep 21, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$116.07awaiting T+60—$111.46 (+3.97%)
Sep 16, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$110.67awaiting T+60—$111.46 (−0.72%)
Sep 11, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$100.82awaiting T+60—$111.46 (+10.56%)
Sep 11, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$100.82awaiting T+60—$111.46 (+10.56%)
Aug 27, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$93.24awaiting T+60—$111.46 (+19.55%)
Aug 27, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$93.24awaiting T+60—$111.46 (+19.55%)
Showing 10 of 29

US Market Status

Market Closed — Opens Wed (10h 14m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 9, 2026